Does Quinidine Gluconate CR Tablet, Extended Release Interact with other Medications?
Severe Interactions
These medications are not usually taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- DISOPYRAMIDE; QUINIDINE/SELECTED AZOLE ANTIFUNGALS
- SELECTED ANTIARRHYTHMICS/SAQUINAVIR
- SELECTED CYP3A4 SUBSTRATES/MIFEPRISTONE
- STRONG CYP2D6 INHIBITORS/VALBENAZINE (> 40 MG)
- P-GLYCOPROTEIN (P-GP) INHIB/COLCHICINE (CARDIOPROTECTION)
- QT PROLONGING AGENTS/LEVOKETOCONAZOLE
- SELECTED CLASS I & CLASS III ANTIARRHYTHMIC AGENTS/SOTALOL
- SLT STRONG & MOD CYP2D6 INHIBIT THAT PROLONG QT/THIORIDAZINE
- QT PROLONGING AGENTS/ANAGRELIDE
- CLASS IA AND III ANTIARRHYTHMIC AGENTS/FINGOLIMOD
- QT PROLONGING AGENTS/DOMPERIDONE
- STRONG CYP2D6 INHIBITORS/PIMOZIDE
- QT PROLONGING AGENTS/DRONEDARONE
- QT PROLONGING AGENTS/ARTEMETHER-LUMEFANTRINE
- QUINIDINE/ALISKIREN
- QT PROLONGING AGENTS/DROPERIDOL
- QT PROLONGING AGENTS/LEVOMETHADYL
- QT PROLONGING AGENTS/BEPRIDIL
- SELECTED ANTIARRHYTHMICS/ZIPRASIDONE
- QUINIDINE/SELECTED PROTEASE INHIBITORS
- QUINIDINE/SERTINDOLE
- SELECTED CLASS IA & III ANTIARRHYTHMICS/CISAPRIDE
- SELECTED ANTIARRHYTHMICS/ARBUTAMINE
- SELECTED CLASS I & III ANTIARRHYTHMICS/MIZOLASTINE
- CHLOROQUINE;HYDROXYCHLOROQUINE;QUINIDINE;QUININE/MEFLOQUINE
- CLASS I AND III ANTIARRHYTHMICS/HALOFANTRINE
- SELECTED AGENTS/MIBEFRADIL
- CLASS IA & III ANTIARRHYTHMICS/SELECTED QUINOLONES
- QUINIDINE/SELECTED ANTIARRHYTHMICS
Serious Interactions
These medications may interact and cause very harmful effects. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- SLT ANTIMALARIALS/STR 3A4 INDUCER;SLT BARBITURATES,HYDANTOIN
- SELECTED ANTIARRHYTHMICS/QUINUPRISTIN-DALFOPRISTIN
- BEPRIDIL; QUINIDINE/STIRIPENTOL
- NATISEDINE; QUINIDINE/TELITHROMYCIN
- QUINIDINE; QUININE/AZITHROMYCIN;ERYTHROMYCIN;TROLEANDOMYCIN
- SELECTED CYP3A4 SUBSTRATES/CERITINIB
- SELECTED ANTIARRHYTHMICS/ELVITEGRAVIR-COBICISTAT
- HYDROQUINIDINE; QUINIDINE/QT PROLONGING AGENTS
- SELECT SENSITIVE CYP3A4 SUBSTRATES THAT PROLONG QT/VOXELOTOR
- SELECTED CYP3A4 SUBSTRATES/CRIZOTINIB
- SELECT SENSITIVE CYP3A4 SUBSTRATES THAT PROLONG QT/TUCATINIB
- SELECTED CYP3A4 SUBSTRATES/PEXIDARTINIB
- QUINIDINE/LONAFARNIB
- SELECTED CYP3A4 SUBSTRATES/SOTORASIB
- SELECT ANTIMALARIALS/STRONG CYP3A4 INDUCERS THAT PROLONG QT
- P-GLYCOPROTEIN (P-GP) INHIBITORS/VINCRISTINE
- QT PROLONGING AGENTS/DEXMEDETOMIDINE SUBLINGUAL
- P-GLYCOPROTEIN (P-GP) INHIBITORS/PRALSETINIB
- QT PROLONGING AGENTS/QUIZARTINIB
- QT PROLONGING AGENTS/ADAGRASIB
- QT PROLONGING AGENTS/PACRITINIB
- QT PROLONGING AGENTS/PANOBINOSTAT
- P-GLYCOPROTEIN (P-GP) INHIBITORS/BILASTINE
- SELECTED QT PROLONGING AGENTS/INTRAVENOUS LEFAMULIN
- QT PROLONGING AGENTS/MOBOCERTINIB
- P-GLYCOPROTEIN (P-GP) INHIBITORS/DOXORUBICIN
- P-GP INHIBITORS/RIMEGEPANT
- QT PROLONGING AGENTS/FEXINIDAZOLE
- P-GLYCOPROTEIN (P-GP) INHIBITORS/RELUGOLIX
- QT PROLONGING AGENTS/LEVOMEPROMAZINE
- SELECTED STRONG CYP2D6 INHIBITORS/TAMOXIFEN
- QT PROLONGING AGENTS/SELPERCATINIB
- QT PROLONGING AGENTS/OXALIPLATIN
- P-GP OR BCRP INHIBITORS THAT PROLONG QT/PAZOPANIB
- P-GP INHIBITORS THAT PROLONG QT/ORAL LEFAMULIN
- QT PROLONGING AGENTS/ENTRECTINIB
- QT PROLONGING AGENTS/GLASDEGIB
- SLT STRONG 2D6 INHIBITOR/ARIPIPRAZOLE LAUROXIL SUBMICRONIZED
- QT PROLONGING AGENTS/LOFEXIDINE
- QT PROLONGING AGENTS/MACIMORELIN
- SELECTED STRONG CYP2D6 INHIBITORS/METOCLOPRAMIDE
- QT PROLONGING AGENTS/INOTUZUMAB OZOGAMICIN
- QT PROLONGING AGENTS/HYDROXYCHLOROQUINE
- QT PROLONGING AGENTS/RIBOCICLIB
- SELECTED P-GLYCOPROTEIN (P-GP) INHIBITORS/VENETOCLAX
- P-GLYCOPROTEIN (P-GP) INHIBITORS/COLCHICINE
- QT PROLONGING AGENTS/HYDROXYZINE
- QT PROLONGING AGENTS/PIMAVANSERIN
- QT PROLONGING AGENTS/VEMURAFENIB
- QT PROLONGING AGENTS/TELAVANCIN
- QT PROLONGING AGENTS/SORAFENIB
- QT PROLONGING AGENTS/ROMIDEPSIN
- QT PROLONGING AGENTS/ONDANSETRON
- QT PROLONGING AGENTS/LENVATINIB
- QT PROLONGING AGENTS/GADOFOSVESET
- QT PROLONGING AGENTS/EZOGABINE
- QT PROLONGING AGENTS/BEDAQUILINE
- QT PROLONGING AGENTS/OSIMERTINIB
- QT PROLONGING AGENTS/PROCAINAMIDE
- QT PROLONGING AGENTS/FLECAINIDE
- QT PROLONGING AGENTS/DELAMANID
- STRONG & MODERATE CYP2D6 INHIBITORS/ELIGLUSTAT
- QT PROLONGING AGENTS/TRAZODONE (>= 100 MG)
- CLASS I & CLASS III ANTIARRHYTHMICS/VERNAKALANT
- QUINIDINE; THIORIDAZINE/SELECTED TRICYCLIC ANTIDEPRESSANTS
- QT PROLONGING AGENTS/QUETIAPINE
- FLECAINIDE; QUINIDINE; VERAPAMIL/DOLASETRON
- QT PROLONGING AGENTS/QUININE
- STRONG CYP2D6 INHIBITORS THAT PROLONG QT/ILOPERIDONE
- QT PROLONGING AGENTS/TOREMIFENE
- P-GLYCOPROTEIN (P-GP) INHIBITORS/TOPOTECAN
- QT PROLONGING AGENTS/ZUCLOPENTHIXOL
- SELECTED P-GLYCOPROTEIN (P-GP) INHIBITORS/DABIGATRAN
- QT PROLONGING AGENTS/NILOTINIB
- QT PROLONGING AGENTS/PALIPERIDONE
- QT PROLONGING AGENTS/IVABRADINE
- AMIODARONE; AJMALINE; QUINIDINE/ATAZANAVIR
- CLASS IA & III ANTIARRHYTHMICS/SELECTED QUINOLONES
- STRONG 2D6 INHIBITORS/ATOMOXETINE; VORTIOXETINE
- QUININE DERIVATIVES/NEUROMUSCULAR BLOCKING AGENTS
- QUINIDINE/DIGITALIS GLYCOSIDES
Moderate Interactions
These medications may cause some risk when taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- QUINIDINE/CIMETIDINE
- QUINIDINE/URINARY ALKALINIZERS
- MEFLOQUINE; QUINIDINE/BETA-BLOCKERS
- SELECTED ANTIARRHYTHMICS/SELECTED PROTEASE INHIBITORS
- HYDROQUINIDINE; QUINIDINE/POSSIBLE QT PROLONGING AGENTS
- SELECTED ANTIARRHYTHMICS/INDINAVIR
- SELECTED P-GLYCOPROTEIN (P-GP) SUBSTRATES/ABROCITINIB
- P-GP INHIBITORS THAT PROLONG QT/MAVORIXAFOR
- STRONG CYP2D6 INHIBITORS/RISPERIDONE INTRAMUSCULAR MONTHLY
- QT PROLONGING AGENTS/ETRASIMOD
- QT PROLONGING AGENTS/GEPIRONE
- SELECT STRONG CYP2D6 INHIBITORS/SLT LONG-ACTING ARIPIPRAZOLE
- QUINIDINE/PATIROMER
- SELECTED STRONG CYP2D6 INHIBITORS/DEXTROMETHORPHAN
- QT PROLONGING AGENTS/TUCIDINOSTAT
- STRONG CYP1A2 OR CYP2D6 INHIBITORS/FENFLURAMINE
- QT PROLONGING AGENTS/TRICLABENDAZOLE
- HYDROQUINIDINE; QUINIDINE/PITOLISANT
- QT PROLONGING AGENTS/OZANIMOD
- QT PROLONGING AGENTS/PONESIMOD
- QT PROLONGING AGENTS/SIPONIMOD
- QT PROLONGING AGENTS/GALANTAMINE
- STRONG CYP2D6 INHIBITORS/MEXILETINE
- STRONG OR MODERATE CYP2D6 OR CYP3A4 INHIBITORS/OLICERIDINE
- QT PROLONGING AGENTS/OSILODROSTAT
- QT PROLONGING AGENTS/AMISULPRIDE
- P-GP OR BCRP INHIBITORS/UBROGEPANT
- SODIUM CHANNEL BLOCKER; POTASSIUM CHANNEL BLOCKER/LACOSAMIDE
- QT PROLONGING AGENTS/GILTERITINIB
- SELECT P-GP INHIBITORS/EDOXABAN (<= 30 MG)
- QT PROLONGING AGENTS/TRAZODONE (< 100 MG)
- SELECTED P-GLYCOPROTEIN (P-GP) INHIBITORS/BETRIXABAN
- STRONG CYP2D6 INHIBITORS/OXYCODONE
- STRONG CYP2D6 INHIBITORS/VALBENAZINE (<=40 MG)
- QT PROLONGING AGENTS/EFAVIRENZ
- QT PROLONGING AGENTS/ERIBULIN
- SELECT P-GP INHIBITORS/EDOXABAN (> 30 MG)
- STRONG CYP2D6 INHIBITORS/BREXPIPRAZOLE
- P-GP AND SELECTED CYP3A4 INHIBITORS/NINTEDANIB
- P-GLYCOPROTEIN (P-GP) INHIBITORS/AFATINIB
- SELECTED MODERATE TO STRONG CYP2D6 INHIBITORS/TRAMADOL
- SELECTED P-GP AND WEAK CYP3A4 INHIBITORS/RIVAROXABAN
- SELECTED ANTIARRHYTHMICS/RANOLAZINE
- QUINIDINE/DEUTETRABENAZINE;TETRABENAZINE
- CYP3A4; CYP2C8; P-GLYCOPROTEIN (P-GP) INHIBITORS/LOPERAMIDE
- CLASS IA AND III ANTIARRHYTHMICS/ABARELIX
- SELECTED CYP2D6 INHIBITORS/PERHEXILINE
- SELECT STRONG CYP2D6 INHIBITORS/ARIPIPRAZOLE
- SELECTED STRONG CYP2D6 INHIBITORS/RISPERIDONE
- STRONG CYP2D6 INHIBITORS/CODEINE
- SELECTED P-GLYCOPROTEIN (P-GP) INHIBITORS/ETOPOSIDE
- QUINIDINE/CALCIUM CHANNEL BLOCKERS
- QUINIDINE/CHOLINERGICS
- QUINIDINE/SELECTED ANTICOAGULANTS (VIT K ANTAGONISTS)
Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.
CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.